Literature DB >> 17880927

A role of RGS proteins in drug addiction.

Shelley B Hooks1, Kirill Martemyanov, Venetia Zachariou.   

Abstract

The diverse family of Regulators of G protein signaling (RGS) proteins are widely distributed proteins with multiple functions, including GAP activity for heterotrimeric G protein alpha subunits. Three members of the RGS family, RGS9-2, RGS4 and RGSz, have been shown to play an essential modulatory role in psychostimulant and opiate drug actions. Interestingly, these proteins show distinct structure, distribution pattern and cellular localization. In addition, each of these proteins is differentially regulated by drugs of abuse in particular brain networks and appears to modulate distinct signal transduction events. The striatal enriched RGS9 plays a prominent role in opiate and psychostimulant drug reward; RGS4 appears to modulate opiate dependence via actions in the locus coeruleus, whereas RGSz modulates analgesia via activation of the PKC pathway.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17880927     DOI: 10.1016/j.bcp.2007.07.045

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  36 in total

1.  Type 5 G protein beta subunit (Gbeta5) controls the interaction of regulator of G protein signaling 9 (RGS9) with membrane anchors.

Authors:  Ikuo Masuho; Hideko Wakasugi-Masuho; Ekaterina N Posokhova; Joseph R Patton; Kirill A Martemyanov
Journal:  J Biol Chem       Date:  2011-04-21       Impact factor: 5.157

2.  Molecular organization of the complex between the muscarinic M3 receptor and the regulator of G protein signaling, Gbeta(5)-RGS7.

Authors:  Simone L Sandiford; Qiang Wang; Konstantin Levay; Peter Buchwald; Vladlen Z Slepak
Journal:  Biochemistry       Date:  2010-06-22       Impact factor: 3.162

3.  RGS4 is a negative regulator of insulin release from pancreatic beta-cells in vitro and in vivo.

Authors:  Inigo Ruiz de Azua; Marco Scarselli; Erica Rosemond; Dinesh Gautam; William Jou; Oksana Gavrilova; Philip J Ebert; Pat Levitt; Jürgen Wess
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-12       Impact factor: 11.205

4.  DHHC protein-dependent palmitoylation protects regulator of G-protein signaling 4 from proteasome degradation.

Authors:  Jincheng Wang; Yan Xie; Dennis W Wolff; Peter W Abel; Yaping Tu
Journal:  FEBS Lett       Date:  2010-10-28       Impact factor: 4.124

5.  RGS9-2: probing an intracellular modulator of behavior as a drug target.

Authors:  John R Traynor; Dimitra Terzi; Barbara J Caldarone; Venetia Zachariou
Journal:  Trends Pharmacol Sci       Date:  2009-02-09       Impact factor: 14.819

Review 6.  Dopamine D2 autoreceptor interactome: Targeting the receptor complex as a strategy for treatment of substance use disorder.

Authors:  Rong Chen; Mark J Ferris; Shiyu Wang
Journal:  Pharmacol Ther       Date:  2020-05-27       Impact factor: 12.310

Review 7.  Regulators of G-protein signaling and their Gα substrates: promises and challenges in their use as drug discovery targets.

Authors:  Adam J Kimple; Dustin E Bosch; Patrick M Giguère; David P Siderovski
Journal:  Pharmacol Rev       Date:  2011-07-07       Impact factor: 25.468

8.  Genetic variations in regulator of G-protein signaling genes as susceptibility loci for second primary tumor/recurrence in head and neck squamous cell carcinoma.

Authors:  Jianming Wang; Scott M Lippman; J Jack Lee; Hushan Yang; Fadlo R Khuri; Edward Kim; Jie Lin; David W Chang; Reuben Lotan; Waun K Hong; Xifeng Wu
Journal:  Carcinogenesis       Date:  2010-07-12       Impact factor: 4.944

9.  RGS2 modulates the activity and internalization of dopamine D2 receptors in neuroblastoma N2A cells.

Authors:  Deborah J Luessen; Tyler P Hinshaw; Haiguo Sun; Allyn C Howlett; Glen Marrs; Brian A McCool; Rong Chen
Journal:  Neuropharmacology       Date:  2016-08-12       Impact factor: 5.250

10.  Retina-specific GTPase accelerator RGS11/G beta 5S/R9AP is a constitutive heterotrimer selectively targeted to mGluR6 in ON-bipolar neurons.

Authors:  Yan Cao; Ikuo Masuho; Haruhisa Okawa; Keqiang Xie; Junko Asami; Paul J Kammermeier; Dennis M Maddox; Takahisa Furukawa; Takayoshi Inoue; Alapakkam P Sampath; Kirill A Martemyanov
Journal:  J Neurosci       Date:  2009-07-22       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.